Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.3 M678 K846 K789 K1.63 M 3.94 M Research & development ————— — Operating income -2.86 M-2.48 M-2.1 M-1.84 M-3.32 M -9.76 M Non-Operating Income, Total 150 K129 K1.38 M132 K176 K 1.82 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 169 K140 K134 K130 K185 K 589 K Unusual income/expense -19 K-11 K1.25 M2 000-9 000 1.23 M Pretax income -2.71 M-2.36 M-723 K-1.71 M-3.15 M -7.94 M Equity in earnings ————— — Taxes ———-1.58 M— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -2.71 M-2.36 M-723 K-1.71 M-3.15 M -7.94 M Discontinued operations ————— — Net income -2.71 M-2.36 M-723 K-1.71 M-3.15 M -7.94 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -2.71 M-2.36 M-723 K-1.71 M-3.15 M -7.94 M Basic earnings per share (Basic EPS) -0.02-0.02-0.01-0.01-0.02 -0.06 Diluted earnings per share (Diluted EPS) -0.02-0.02-0.01-0.01-0.02 -0.06 Average basic shares outstanding 123.87 M124.93 M125.36 M125.16 M131.6 M — Diluted shares outstanding 123.87 M124.93 M125.36 M125.16 M131.6 M — EBITDA -1.28 M-655 K-824 K-768 K-1.59 M -3.84 M EBIT -1.3 M-678 K-846 K-789 K-1.63 M -3.94 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 22 K23 K22 K21 K36 K 102 K